These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 7030272)
21. An attempt at the use of immunological methods for the detection of enzymes of BCG substrains. Lipińska R; Rzucidło L Acta Microbiol Pol; 1978; 27(1):25-34. PubMed ID: 76421 [TBL] [Abstract][Full Text] [Related]
22. [Cloning and identification of the Mycobacterium bovis BCG gene for signal peptide of antigen 85-B]. Zeng X; Wang G; Lu Y Zhonghua Jie He He Hu Xi Za Zhi; 1996 Dec; 19(6):350-2. PubMed ID: 9596817 [TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of Mycobacterium bovis BCG: Romanian sub-strain. Balazs D; Cojocaru R; Damian M Int J Tuberc Lung Dis; 1999 Jun; 3(6):542-5. PubMed ID: 10383071 [TBL] [Abstract][Full Text] [Related]
24. [Characterization of mycobacterial antigens of sea lions]. Alito A; Zumárraga MJ; Bigi F; Romano MI; Cataldi A Rev Argent Microbiol; 1999; 31 Suppl 1():6-9. PubMed ID: 10509397 [No Abstract] [Full Text] [Related]
25. Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guérin (BCG) substrains. Hayashi D; Takii T; Fujiwara N; Fujita Y; Yano I; Yamamoto S; Kondo M; Yasuda E; Inagaki E; Kanai K; Fujiwara A; Kawarazaki A; Chiba T; Onozaki K FEMS Immunol Med Microbiol; 2009 Jul; 56(2):116-28. PubMed ID: 19453755 [TBL] [Abstract][Full Text] [Related]
27. [Use of immunologic methods for the detection of dehydrogenases of BCG substrains]. Lipińska R Pneumonol Pol; 1976 Feb; 44(2):113-8. PubMed ID: 821044 [No Abstract] [Full Text] [Related]
28. Quality controls and in vitro diagnostic efficiency of bovine PPD tuberculins. Tameni S; Amadori M; Scaccaglia P; Quondam-Giandomenico R; Tagliabue S; Achetti IL; Adone R; Ciuchini F Biologicals; 1998 Sep; 26(3):225-35. PubMed ID: 10208724 [TBL] [Abstract][Full Text] [Related]
29. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination. Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857 [TBL] [Abstract][Full Text] [Related]
30. Increased serum anti-mycobacterial antibody titers in rheumatoid arthritis patients. Is there any specific antigenic target? Cetin ES; Aksoy AM Saudi Med J; 2007 May; 28(5):717-22. PubMed ID: 17457438 [TBL] [Abstract][Full Text] [Related]
36. The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis. Andersen CS; Dietrich J; Agger EM; Lycke NY; Lövgren K; Andersen P Infect Immun; 2007 Jan; 75(1):408-16. PubMed ID: 17074845 [TBL] [Abstract][Full Text] [Related]
37. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection. Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343 [TBL] [Abstract][Full Text] [Related]
38. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259 [TBL] [Abstract][Full Text] [Related]
39. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. Black GF; Dockrell HM; Crampin AC; Floyd S; Weir RE; Bliss L; Sichali L; Mwaungulu L; Kanyongoloka H; Ngwira B; Warndorff DK; Fine PE J Infect Dis; 2001 Aug; 184(3):322-9. PubMed ID: 11443558 [TBL] [Abstract][Full Text] [Related]